PhRMA
DECEMBER 19, 2022
Recently, industry leaders, regulators, academics, data partners, and patient advocates gathered in Washington, D.C., to discuss using real-world data and real-world evidence for regulatory decision-making. The discussion explored emerging analytical methodologies to address the challenge of mitigating sources of bias and confounding variables that come up in nearly all sources of real-word data.
Pharmacy Times
DECEMBER 19, 2022
Traditionally, endemic fungi are characterized by geographical distribution, however, disease-causing fungi may infect people beyond these havens.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 19, 2022
A collaboration between academic centres in the UK has won government funding for a digital approach to dysfunctional breathing or dyspnoea, a symptom that affects around 10% of the population. The Engineering and Physical Sciences Research Council (EPSRC) has set aside £400,000 (almost $490,000) for the project, which will help fund work at the Universities of Plymouth, Salford and Stirling, and the Glasgow School of Art.
Pharmacy Times
DECEMBER 19, 2022
Although physical activity and the practice of being present in the moment are associated with many benefits, analysis shows that neither led to measurable improvements in brain health.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
DECEMBER 19, 2022
The US Food and Drug Administration (FDA) has approved Swiss drugmaker Ferring Pharmaceuticals’ Adstiladrin (nadofaragene firedenovec-vncg) for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumours. Bladder cancer is one of the more common forms of cancer.
Pharmacy Times
DECEMBER 19, 2022
Investigators establish that audio and/or facial video features have been most analyzed by machine learning, followed by electroencephalography signals.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
DECEMBER 19, 2022
Treatment observably eased obsessive-compulsive disorder symptom severity in young patients, however, symptoms still caused students to be absent from school at least 2 days every month.
European Pharmaceutical Review
DECEMBER 19, 2022
A new £2.4 million Phase III trial will determine if ketamine-assisted therapy can help those with severe alcohol use disorder to stay off alcohol for longer. Led by the University of Exeter and funded by the Medical Research Council (MRC) and the National Institute for Health and Care Research (NIHR), “[t]his is the largest trial of its kind in the world and builds on our earlier, smaller positive trial,” stated Professor Anne Lingford-Hughes, Professor of Addiction Biology at Imperial College
Pharmacy Times
DECEMBER 19, 2022
Cariprazine (Vraylar; AbbVie, Gedeon Richter) is indicated as an adjunctive therapy to antidepressants for treating adult patients with major depressive disorder.
Pharmaceutical Technology
DECEMBER 19, 2022
Sanofi has extended the partnership with Innate Pharma for natural killer (NK) cell therapeutics in oncology. With the latest development, Sanofi will licence a NK cell engager programme that acts on B7H3 from the antibody-based NK cell engager therapeutics (ANKET) platform of Innate. Under the latest licence deal, Sanofi will make an upfront payment of $26.4m (€25m) to Innate.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
DECEMBER 19, 2022
An array of complications may arise associated with treatment of hemophilia A.
Drug Topics
DECEMBER 19, 2022
The Medicare Part D Senior Savings Model — a CMS effort to test $35 copays for insulin — led to lowered total costs for beneficiaries.
Pharmacy Times
DECEMBER 19, 2022
Tim Whitten, BSPharm, MBA, CEO & President of Taiho Oncology Inc discusses the critical impacts of pharmacists across the health care landscape.
Fierce Pharma
DECEMBER 19, 2022
Atara makes history with world-first nod for allogeneic T-cell therapy Ebvallo. fkansteiner. Mon, 12/19/2022 - 14:06.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
DECEMBER 19, 2022
Age was a contributing factor of chronic kidney disease and albuminuria in patients with type 1 and type 2 diabetes.
STAT
DECEMBER 19, 2022
WASHINGTON — Leaders in Congress have reached a sweeping deal to ease Medicare pay cuts to doctors, make major changes to post-pandemic Medicaid policy, and to help prepare for future pandemics. Lawmakers are aiming to pass a health care policy package along with legislation to fund the federal government by Friday. The details of the omnibus spending package were confirmed by two lobbyists and two congressional aides.
Pharmacy Times
DECEMBER 19, 2022
Specific immune checkpoint inhibitors added to frontline chemotherapy have transformed modern clinical practice.
STAT
DECEMBER 19, 2022
Northern Maine and southern California don’t seem to have a lot in common — until you start looking for affordable, accessible dental care. In such disparate communities, and thousands in between, millions of Americans can’t access the dental care they need. Not having access to dental care can lead to serious oral and overall health issues , not to mention more intensive care later on.
Pharmacy Times
DECEMBER 19, 2022
Identifying how survivors adjust to their cancer may help health care providers provide tailored self-management skills.
STAT
DECEMBER 19, 2022
With much of the nation’s illicit drug supply contaminated by fentanyl, test strips that detect the dangerous synthetic opioid can help people who use drugs prevent a deadly overdose. These tests are inexpensive and effective, but they remain inaccessible for many people in the U.S. and are illegal in many states. In this video, learn about how fentanyl test strips work, how they can reduce harm from drug use, and why they are controversial around the country.
Pharmacy Times
DECEMBER 19, 2022
Atta Chowdhry, RPh, opens a discussion surrounding prophylactic treatment in patients diagnosed with hemophilia A.
Fierce Healthcare
DECEMBER 19, 2022
2023 forecast: Providers embrace start of new requirements on health equity. rking. Mon, 12/19/2022 - 15:28.
STAT
DECEMBER 19, 2022
At first, Lena Harvey didn’t realize anything had changed. She just started doing strange, unexpected things: Cleaning her living room, for example, or playing with her puppy, a black schnauzer named Apollo. It hit her as she walked in from the patio one day. She looked at her husband, Anthony, and asked, “Honey, I haven’t been complaining about pain, have I?
pharmaphorum
DECEMBER 19, 2022
Amicus Therapeutics could be just weeks away from getting EU approval for its new Pompe disease therapy Pombiliti after getting a positive opinion on the drug from the EMA’s human medicines committee. The CHMP said late last week it was recommending Pombiliti (cipaglucosidase alfa or ATB200) as an infused therapy for late-onset Pompe disease in adults given in combination with the enzyme stabiliser miglustat in a regimen known as AT-GAA.
STAT
DECEMBER 19, 2022
A bill that makes it easier for the Food and Drug Administration to withdraw drugs that were approved under an accelerated timeline also dropped provisions the industry had opposed, according to three drug lobbyists. The legislation was spurred by the fracas over the Alzheimer’s drug Aduhelm, which received a so-called accelerated approval. Nearly every member of an FDA advisory panel voted against approving the Biogen drug, though many advocates for patients with debilitating conditions
Drug Store News
DECEMBER 19, 2022
Shoppers across Michigan, Indiana, Illinois, Ohio, Wisconsin and Kentucky can access same-day delivery on grocery items, including fresh produce, prepared meals and more through Uber Eats.
European Pharmaceutical Review
DECEMBER 19, 2022
The US Food and Drug Administration (FDA) has approved Adstiladrin (nadofaragene firadenovec-vncg) as the first gene therapy for non-muscle-invasive bladder cancer (NMIBC) in adults with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive with carcinoma in situ (CIS) with or without papillary tumours. Dr Peter Marks, PhD, Director of the FDA’s Center for Biologics Evaluation and Research observed that Adstiladrin, the non-replicating adenoviral vector-based therapy provides “… an innovative tr
Pharmacy Times
DECEMBER 19, 2022
The additional indication expands its therapeutic role beyond advanced non-small cell lung cancer.
STAT
DECEMBER 19, 2022
Next year, two curative gene therapies could be approved for sickle cell disease. Yet drugmakers are pouring billions into developing new and more conventional drugs for the disease, even if they are likely to be far less transformative for individual patients. The mismatch comes from the fact that current gene therapies take too steep a toll on the body to be given to more than a fraction of patients in the U.S. and Europe.
Fierce Pharma
DECEMBER 19, 2022
Novartis prunes nearly 300 jobs in Garden State as corporate slimdown rolls on. fkansteiner. Mon, 12/19/2022 - 10:53.
Drug Store News
DECEMBER 19, 2022
Colleen Lindholz, president of Kroger Health, discusses the Food as Medicine platform and its mission to help people enjoy food so they can live healthier lives.
STAT
DECEMBER 19, 2022
WASHINGTON — The Food and Drug Administration’s Center for Tobacco Products is lacking clear goals — and that lack of vision is hampering its ability to regulate millions of tobacco products currently on the market, according to an external review of the center released Monday. “The Center’s current goals and priorities are unclear in communication and practice,” the review states.
Fierce Healthcare
DECEMBER 19, 2022
Epic plans to overhaul its app market, opens new 'connection hub' for developers. Here are key things to know. hlandi. Mon, 12/19/2022 - 11:56.
Drug Store News
DECEMBER 19, 2022
CMS proposes that issuers of standardized plan options must place all covered generic drugs in the standardized plan options’ generic drug cost-sharing tier.
Expert insights. Personalized for you.
214 
Let's personalize your content